Brief: Titan Pharmaceuticals To Acquire JT Pharma's Kappa Opioid Agonist Peptide
28/10/2020 12:18
Oct 28 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ENTERS INTO DEFINITIVE AGREEMENT TO
ACQUIRE JT PHARMA'S KAPPA OPIOID AGONIST PEPTIDE, JT-09
* TITAN PHARMACEUTICALS - JT PHARMA IS ENTITLED TO RECEIVE
FROM CO
FUTURE MILESTONE PAYMENTS BASED ON ACHIEVEMENT OF REGULATORY
MILESTONES
* TITAN PHARMACEUTICALS - JT PHARMA IS ALSO ENTITLED TO GET
FROM
CO SINGLE-DIGIT PERCENTAGE EARN-OUT PAYMENTS ON NET SALES OF
PRODUCT
* TITAN PHARMACEUTICALS - LOOKING FORWARD TO CONDUCTING
ADDITIONAL
PRECLINICAL STUDIES TO ESTABLISH PROOF-OF-CONCEPT WITH DATA
AVAILABLE IN H1 2021
Source text for Eikon: ID:nPn5GCzT9a
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.